Bph News

Urologists treating patients with lower urinary tract symptoms , which suggest benign prostatic hyperplasia , should counsel patients on the increased risk that LUTS/BPH and BPH treatment present for ejaculatory dysfunction, according to a literature review published in the July issue of Urology .

Main Category: Urology / Nephrology Also Included In: Pharma Industry / Biotech Industry Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces positive results from a Phase IIa clinical trial of its lead development compound VA106483 for nocturia.

Q: Can Flomax interfere with cataract surgery? A: It may, according to a large study recently reported in The Journal of the American Medical Association .

AEterna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that patient follow-up in the open-label safety study of its Phase 3 program in benign prostatic hyperplasia with its lead endocrinology compound, cetrorelix pamoate, is scheduled to be completed at the end of this week.

BAR HARBOR : Men in the MDI region suffering from an enlarged prostate, known as benign prostate hyperplasia , now have a treatment available that avoids side effects and expense of medication, and the risks associated with invasive surgery.

Nearly everyone has had eye dryness on occasion. Perhaps you've noticed it after working on the computer for a long stretch.

Benign prostatic hyperplasia affects nearly 3 of 4 men by the age of 70 years, with symptoms of BPH including urination difficulties.

Many older men take a drug called Flomax for a condition called BPH or Benign Prostate Enlargement.

Chaim M. Bell, MD, PhD ; Wendy V. Hatch, OD, MSc ; Hadas D. Fischer, MD ; Geta Cernat, MD, MSc ; J. Michael Paterson, MSc ; Andrea Gruneir, PhD ; Sudeep S. Gill, MD, MSc ; Susan E. Bronskill, PhD ; Geoffrey M. Anderson, MD, PhD ; Paula A. Rochon, MD, MPH JAMA.

Use of the medication tamsulosin to treat male urination difficulties within two weeks of cataract surgery is associated with an increased risk of serious postoperative ophthalmic adverse events such as retinal detachment or lost lens, according to a study in the May 20 issue of JAMA .

May 19, 2009 -- Men who take the drug Flomax within two weeks of cataract surgery are at risk of serious eye complications, including a detached retina or lost lens, according to a new study published in the Journal of the American Medical Association .

Use of the medication tamsulosin to treat male urination difficulties within two weeks of cataract surgery is associated with an increased risk of serious postoperative ophthalmic adverse events such as retinal detachment or lost lens, according to a study in the May 20 issue of JAMA .

Transurethral resection of the prostate is used to treat moderate to severe enlargement of the prostate gland .

Nymox Pharmaceutical Corporation reported today that NX02-0018, the second Phase 3 U.S. clinical trial for NX-1207, the Company's investigational drug for BPH, has begun screening and enrolment of patients.

DEAR DR. DONOHUE : For men with BPH, would you recommend the Prolieve System for treatment? It involves reducing the prostate with heat.

Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, today announced that detailed data from the Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia , will be presented at the 2009 Annual Meeting of the American Urological Association .

Researchers from Dendreon Corporation today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small molecule, which targets TRPM8 , to treat benign prostatic hyperplasia .

Data to be presented at the American Urological Association's Annual Conference show that RAPAFLO produces rapid and sustained improvements of both irritative and obstructive urinary symptoms associated with BPH, with statistically significant symptom relief within three to four days of starting treatment.

Main Category: Urology / Nephrology Also Included In: Medical Devices / Diagnostics Article Date: 26 Apr 2009 Urologix , Inc.

LINTHICUM, MD, April 26, 2009-Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia .